36th Annual Psychopharmacology Update: Treatment Refractory Depression; Novel Interventions

Friday, September 21, 2018, 9:00 AM to 4:15 PM

Located at The Brady Center on the Main Campus of the University of Toledo in Nitschke Technology Commercialization Complex. 

The 36th Psychopharmacology Update is a continuing education program for psychiatrists, psychologists, family medicine practitioners, internal medicine physicians, social workers, nurse practitioners, counselors and therapists. The goal of the Program is to provide an update on psychophar-macology for behavioral health and depression treatments. 

Learning Objectives by Presentation:
  • Novel Strategies for Transcranial Magnetic Stimulation for Depression
    • Describe Transcranial Magnetic Stimulations (TMS) outcomes and uses for depression
    • List new strategies/approaches in the use of TMS for depression
    • Identify biological mechanisms for the newer TMS strategies for depression.
  • Life in the Fast Lane: Rapidly Acting Antidepressants
    • Recognize limitations of current depression treatment
    • Recognize evidence for Ketamine for depression
    • Identify risks and benefits of rapidly acting antide-pressants
  • New Developments on the Pharmacological Treatment of Depression
    • Review new approaches to the pharmacologic treat-ment of depression reported in peer-reviewed pub-lications and FDA approval studies
    • Discuss proposed mechanisms of action the emerg-ing treatments
    • Discuss implications of this research for the current treatment of depression
  • Desensitizing an anxious nervous system via Floatation-REST
    • Describe the ways in which Floatation-REST re-duces environmental stimulation of the nervous system
    • Recognize the neurophysiological effects of Floata-tion-REST
    • Discuss recent clinical trials documenting the anxi-olytic and stress-reducing effects of Floatation-REST in anxious populations
  • ECT: Where we have been and where we are going
    • Recognize historical context of ECT and develop-ment of stigma.
    • Recognize the difference between modalities of ECT and rationale of how to choose between mo-dalities.
    • Recognizing barriers that interfere with access to care for ECT.

Download the brochure (PDF)

Last Updated: 6/27/22